This inventor holds 1 USPTO granted patent. Top assignees: Kyowa Hakko Kogyo Co., Ltd., Kyowa Medex Co., Ltd., Tokai University. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2009
Title: Kiyoshi Ando: Innovator in Leukemia Diagnosis
Introduction
Kiyoshi Ando is a notable inventor based in Chigasaki, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the area of leukemia and related blood diseases. His innovative work has the potential to improve the accuracy of diagnoses and treatment options for patients.
Latest Patents
Kiyoshi Ando holds a patent for a method of judging leukemia, pre-leukemia, or aleukemic malignant blood diseases. This patent, which includes 1 patent, outlines a comprehensive approach to diagnosing these conditions. The invention focuses on methods for discriminating between leukemia and pre-leukemia, as well as diagnosing delayed engraftment of hematopoietic stem cells after transplantation. It also provides a means for diagnosing graft versus host disease, utilizing the quantification of stem cell growth factor (SCGF) as a key component.
Career Highlights
Throughout his career, Kiyoshi Ando has worked with esteemed institutions such as Tokai University and Kyowa Medex Co., Ltd. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to advancements in medical technology.
Collaborations
Kiyoshi Ando has collaborated with notable colleagues, including Chie Ito and Akiko Furuya. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Kiyoshi Ando's contributions to the field of leukemia diagnosis exemplify the impact of innovative thinking in medicine. His patent and collaborative efforts highlight the importance of research and development in improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile